High Vista Strategies LLC Black Diamond Therapeutics, Inc. Transaction History

High Vista Strategies LLC

  • $242 Million
  • Q4 2024

Shares

4 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q2 2021

Aug 16, 2021
SELL
$12.19 - $28.17 $326,326 - $754,110
-26,770 Closed
0 $0
Q1 2021

May 17, 2021
BUY
$22.23 - $34.75 $595,097 - $930,257
26,770 New
26,770 $649,000
Q4 2020

Feb 16, 2021
SELL
$29.47 - $35.0 $483,042 - $573,685
-16,391 Closed
0 $0
Q3 2020

Nov 16, 2020
BUY
$26.17 - $43.07 $428,952 - $705,960
16,391 New
16,391 $496,000

Others Institutions Holding BDTX

# of Institutions
93
Shares Held
47.4M
Call Options Held
2.9K
Put Options Held
69.4K
View Full List

About Black Diamond Therapeutics, Inc.

BDTX Quotes by TradingView
  • Ticker BDTX
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Biotechnology
  • Shares Outstandng 36,339,500
  • Market Cap $50.9M
  • Description
  • Black Diamond Therapeutics, Inc., a biotechnology company, discover, develops, and commercializes medicines for patient with genetically defined tumors. It develops BDTX-189, an irreversible small molecule inhibitor that is designed to targets oncogenic proteins defined by the non-canonical epidermal growth factor receptor (EGFR) and human epide...
More about BDTX
Track This Portfolio

Track High Vista Strategies LLC Portfolio

Follow High Vista Strategies LLC and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of High Vista Strategies LLC, based on Form 13F filings with the SEC.

News

Stay updated on High Vista Strategies LLC with notifications on news.

Choose your preferred platform and Sign Up 👇 Telegram Email